Charter Research & Investment Group, Inc. Merck & Co., Inc. Transaction History

Charter Research & Investment Group, Inc.

$126 Million
Q1 2024

A detailed history of Charter Research & Investment Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Charter Research & Investment Group, Inc. holds 35,404 shares of MRK stock, worth $4.43 Million. This represents 3.7% of its overall portfolio holdings.

Number of Shares

35,404

Previous 34,902 1.44%

Holding current value

$4.43 Million

Previous $3.81 Million 22.76%

% of portfolio

3.7%

Previous 3.16%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$113.24 - $131.95 $56,846 - $66,238	502 Added 1.44%	35,404 $4.67 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $45,298 - $50,305	-440 Reduced 1.24%	34,902 $3.59 Million
Q2 2023 Aug 10, 2023	SELL	$108.61 - $118.38 $24,437 - $26,635	-225 Reduced 0.63%	35,342 $4.08 Million
Q1 2023 May 08, 2023	BUY	$102.94 - $114.86 $3,088 - $3,445	30 Added 0.08%	35,567 $3.78 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $3,497 - $4,484	-40 Reduced 0.11%	35,537 $3.94 Million

Q3 2022 Nov 10, 2022	SELL	$84.53 - $94.96 $102,281 - $114,901	-1,210 Reduced 3.29%	35,577 $3.06 Million
Q2 2022 Aug 10, 2022	SELL	$83.49 - $94.64 $3,339 - $3,785	-40 Reduced 0.11%	36,787 $3.35 Million
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $69,099 - $77,456	-940 Reduced 2.49%	36,827 $3.02 Million
Q4 2021 Feb 10, 2022	BUY	$72.28 - $90.54 $3,614 - $4,527	50 Added 0.13%	37,767 $2.89 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $14,336 - $15,766	200 Added 0.53%	37,717 $2.83 Million
Q2 2021 Aug 10, 2021	SELL	$70.31 - $77.77 $44,506 - $49,228	-633 Reduced 1.66%	37,517 $2.92 Million
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $22,379 - $26,360	325 Added 0.86%	38,150 $2.94 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $16,865 - $18,717	235 Added 0.63%	37,825 $3.09 Million
Q3 2020 Nov 10, 2020	SELL	$73.18 - $82.95 $85,620 - $97,051	-1,170 Reduced 3.02%	37,590 $3.12 Million
Q2 2020 Aug 12, 2020	BUY	$70.42 - $80.13 $68,659 - $78,126	975 Added 2.58%	38,760 $3 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $9,504 - $13,172	150 Added 0.4%	37,785 $2.91 Million
Q4 2019 Jan 30, 2020	SELL	$77.58 - $87.54 $1,474 - $1,663	-19 Reduced 0.05%	37,635 $3.42 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $78,742 - $85,832	1,035 Added 2.83%	37,654 $3.17 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $55,173 - $64,456	-790 Reduced 2.11%	36,619 $3.07 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $20,874 - $23,808	-300 Reduced 0.8%	37,409 $3.11 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $58,063 - $67,381	-890 Reduced 2.31%	37,709 $2.88 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $23,076 - $27,136	-400 Reduced 1.03%	38,599 $2.74 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $16,256 - $18,894	319 Added 0.82%	38,999 $2.12 Million
Q4 2017 Feb 02, 2018	BUY	$51.62 - $61.64 $2 Million - $2.38 Million	38,680	38,680 $2.18 Million

Others Institutions Holding MRK

# of Institutions

3,773

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $317B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charter Research & Investment Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Charter Research & Investment Group, Inc. with notifications on news.

Account

Charter Research & Investment Group, Inc. Merck & Co., Inc. Transaction History